PML bodies associate specifically with the MHC gene cluster in interphase nuclei

Journal of Cell Science

Volumn 114, Issue 20, 2001, Pages 3705-3716

  Shiels, C ^a   Islam, S A ^a   Vatcheva, R ^a   Sasieni, P ^a   Sternberg, M J E ^a   Freemont, P S ^a   Sheer, D ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Immuno FISH; Major histocompatibility complex; Nuclear organisation; PML nuclear body; Transcription

Indexed keywords

NUCLEIC ACID BASE; RNA;

ARTICLE; CELL COMPARTMENTALIZATION; CELL NUCLEUS; CENTROMERE; CHROMOSOME; CHROMOSOME 6; CONTROLLED STUDY; DISEASE ASSOCIATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE CLUSTER; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INTERPHASE; MAJOR HISTOCOMPATIBILITY COMPLEX; MODEL; OBSERVATION; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN DOMAIN; SPATIAL ORIENTATION; THREE DIMENSIONAL IMAGING; VIRUS GENOME; VIRUS TRANSCRIPTION;

CELL NUCLEUS; CELLS, CULTURED; CHROMOSOMES, HUMAN, PAIR 6; FIBROBLASTS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROSCOPY, FLUORESCENCE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0034759620     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein
2. Microinjection of anti-coilin antibodies affects the structure of coiled bodies
3. Intracellular localization of proteasomal degradation of a viral antigen
4. Evolutionary dynamics of non-coding sequences within the class II region of the human MHC
5. Cellular responses to interferon-gamma
6. Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA
7. The solution structure of the RING finger domain from the acute promyelocytic leukaemia protooncoprotein PML
8. Two RING finger proteins, the oncoprotein PML and the arenavirus Z protein, colocalize with the nuclear fraction of the ribosomal P proteins
9. Identification of an interchromosomal compartment by polymerization of nuclear-targeted vimentin
10. Discrete nuclear domains of poly(A) RNA and their relationship to the functional organization of the nucleus
11. Further evidence for the involvement of human chromosome 6p24 in the aetiology of orofacial clefting
12. Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to have decreased expression of class II antigens
13. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR
14. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
15. Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation
16. Generation of novel human MHC class II mutant B-cell lines by integrating YAC DNA into a cell line homozygously deleted for the MHC class II region
17. Cell cycle dependent chromosomal movement in pre-mitotic human T-lymphocyte nuclei
18. Coiled bodies contain U7 small nuclear RNA and associate with specific DNA sequences in interphase human cells
19. Association of snRNA genes with coiled bodies is mediated by nascent snRNA transcripts
20. Transcriptional regulation of MHC class I genes
21. Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia
22. Isolation and ordering of HLA class I region cosmids
23. PML-containing nuclear bodies: Their spatial distribution in relation to other nuclear components
24. Inhibition of RNA polymerase II transcription causes chromatin decondensation, loss of nucleolar structure, and dispersion of chromosomal domains
25. TAPASIN, DAXX, RGL2, HKE2 and four new genes (BING 1, 3 to 5) form a dense cluster at the centromeric end of the MHC
26. Genomic structure and domain organisation of the human Bak gene
27. Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies
28. Transcription factor AP-2 mRNA and DNA binding activity are constitutively expressed in SV40-immortalized but not normal human lung fibroblasts
29. Human cytomegalovirus immediate early interaction with host nuclear structures: Definition of an immediate transcript environment
30. PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1
31. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML
32. The t(15;17) translocation alters a nuclear body in a retinoic acid- reversible fashion
33. Active and inactive genes localize preferentially in the periphery of chromosome territories
34. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body
35. Alteration of the PML proto-oncogene in leukemic cells does not abrogate expression of MHC class I antigens
36. The acute promyelocytic leukaemia-associated PML gene is induced by interferon
37. Nuclear domain 10, the site of DNA virus transcription and replication
38. Nuclear redistribution of BRCA1 during viral infection
39. Review: Properties and assembly mechanisms of ND10, PML bodies, or PODs
40. Genes, genes and more genes in the human major histocompatibility complex
41. Proteasome-mediated degradation of transcriptional activators correlates with activation domain potency in vivo
42. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus
43. In vivo degradation of RNA polymerase II largest subunit triggered by alpha-amanitin
44. Identification of a novel cis-acting element for fibroblast-specific transcription of the FSP1 gene
45. Fine mapping of 39 ESTs on human chromosome 6p23-p25
46. Non-apoptotic chromosome condensation induced by stress: Delineation of interchromosomal spaces
47. Regulation of class II MHC expression
48. The puzzling multiple lives of PML and its role in the genesis of cancer
49. Functional overlap of sequences that activate transcription and signal ubiquitin-mediated proteolysis
50. The S100 family of EF-hand calcium-binding proteins: Functions and pathology
51. The RNA 3′ cleavage factors CstF 64 kDa and CPSF 100 kDa are concentrated in nuclear domains closely associated with coiled bodies and newly synthesized RNA
52. The PML nuclear bodies: Actors or extras?
53. IFN-gamma-mediated coordinated transcriptional regulation of the human TAP-1 and LMP-2 genes in human renal cell carcinoma
54. Dynamic elastic behavior of alpha-satellite DNA domains visualized in situ in living human cells
55. Processing of endogenous pre-mRNAs in association with SC-35 domains is gene specific
56. Human epidermal differentiation complex in a single 2.5 Mbp long continuum of overlapping DNA cloned in bacteria integrating physical and transcript maps
57. Macromolecular domains within the cell nucleus
58. Interrelationships of nuclear structure and transcriptional control: Functional consequences of being in the right place at the right time
59. Nuclear dots: Actors on many stages
60. A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies
61. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis
62. PML nuclear bodies are general targets for inflammation and cell proliferation
63. Complete sequence and gene map of a human major histocompatibility complex
64. Physical map of human 6p21.2-6p21.3: Region flanking the centromeric end of the major histocompatibility complex
65. 'Both man & bird & beast': Comparative organization of MHC genes
66. The promyelocytic leukemia protein interacts with Sp1 and inhibits its transactivation of the epidermal growth factor receptor promoter
67. A bipartite sequence element associated with matrix/scaffold attachment regions
68. Spatial relationship between transcription sites and chromosome territories
69. Large-scale chromatin organization of the major histocompatibility complex and other regions of human chromosome 6 and its response to interferon in interphase nuclei
70. CREB-binding protein (CBP)/p300 and RNA polymerase II colocalize in transcriptionally active domains in the nucleus
71. Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells
72. Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter
73. Proto-oncogene PML controls genes devoted to MHC class I antigen presentation
74. A role for PML and the nuclear body in genomic stability
75. Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis
76. Role of SUMO-1-modified PML in nuclear body formation
77. The transcriptional role of PML and the nuclear body